ClinicalTrials.govpublic full text
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
graft versus host disease, gvhd, allogeneic transplant, gvhd prevention, unrelated donors, mismatched unrelated donors, hematological malignancies, leukemia, lymphoma, myelodysplastic syndrome, myelofibrosis, aplastic anemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 841539
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.